MedNous Article: How Antigen Discovery Could Redefine Multiple Myeloma

CSO Dr Rosanne Dunn's writeup on HaemaLogiX's antigen discovery was featured in the March 2026 edition of MedNous, a leading international business-science publication for the biotech industry. Read the article here.